EDITORIAL
A complex archetype
First published: 13 February 2021
No abstract is available for this article.
REFERENCES
- 1Pal R, Banerjee M, Bhadada SK. Glycaemic efficacy and safety of mealtime faster-acting insulin aspart administered by injection as compared to insulin aspart in people with diabetes mellitus: a meta-analysis of randomized controlled trials. Diabet. Med. 2021; 1-11. https://doi.org/10.1111/dme.14515
- 2Miller KM, Beck RW, Foster NC, Maahs DM. HbA1c levels in type 1 diabetes from early childhood to older adults: a deeper dive into the influence of technology and socio-economic status on HbA1c in the T1D Exchange Clinic Registry Findings. Diabetes Technol Ther. 2020; 22: 645-651.
- 3James S, Pryke A, Cusumano J, et al. 20-year outcomes of childhood-onset type 1 diabetes: the CANDID incident cohort survey. Diabet Med. 2020; 3–5. https://doi.org/10.1111/dme.14473
- 4 Group, D. S. Training in flexible, intensive insulin management to enable dietary freedom in people with Type 1 diabetes: dose adjustment for normal eating (DAFNE) randomized controlled trial. BMJ. 2002; 325: 746.
- 5Elliott J, et al. Substantial reductions in the number of diabetic ketoacidosis and severe hypoglycaemia episodes requiring emergency treatment lead to reduced costs after structured education in adults with Type 1 diabetes. Diabet Med. 2014; 31: 847-853.
- 6Erdal B, Caferoglu Z, Hatipoglu N. The comparison of two mealtime insulin dosing algorithms for high and low glycaemic index meals in adolescents with type 1 diabetes. Diabet Med. 2020; 1–9. https://doi.org/10.1111/dme.14444
